Literature DB >> 27012877

Factors associated with length of stay in intensive care after bariatric surgery.

Dvir Froylich1, Ricard Corcelles2, Matthew Davis1, Mena Boules1, Christopher R Daigle1, Philip R Schauer1, Stacy A Brethauer3.   

Abstract

BACKGROUND: Although uncommon, admission to the intensive care unit (ICU) after bariatric surgery may be necessary. This study evaluates characteristics of bariatric surgery patients that are admitted to the ICU, and identifies possible risk factors for increased ICU length of stay (LOS).
SETTING: Academic hospital, United States.
METHODS: A retrospective review of all ICU admissions after bariatric surgery from 2006 to 2013 was performed. Demographic characteristics and perioperative data were extracted, and risk factors for the LOS and mortality in the ICU were analyzed.
RESULTS: In total, 124 out of 4398 (2.8%) patients were admitted to the ICU after bariatric surgery. The mean age of these patients was 52.7±11.8 years and included 79 female patients (64%). There were 19 nonemergent or planned admissions (15.3%) and 105 unplanned admissions (84.7%). Mean body mass index was 47.8±12.2 kg/m2, and mean American Society of Anesthesiology (ASA) score was 3.1±0.6. Roux-en-Y gastric bypass, sleeve gastrectomy, and adjustable gastric banding were performed in 80 (65%), 18 (15%), and 6 (5%) patients, respectively. Revisional procedures were performed in 15 (12%) patients. Respiratory failure was the most common cause for admission, occurring in 35 (28.2%) patients. The most common surgical complications requiring ICU admission were bleeding (n = 27) and anastomotic leak (n = 21). Mean ICU LOS was 6.0±9.6 (1-65) days. Mortality occurred in 5 (4.0%) patients. Based on univariate analysis, risk factors associated with ICU LOS were conversion from laparoscopic to open approach, anastomotic leak, time from operation to ICU admission, and reoperation. Higher ASA score was a significant risk factor for mortality.
CONCLUSION: ICU admission after bariatric surgery is uncommon but is associated with a significantly increased mortality. Anastomotic leak, conversions, time from operation to ICU admission, and reoperation have the greatest impact in determining the LOS in the ICU after bariatric surgery.
Copyright © 2016 American Society for Bariatric Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bariatric surgery; Intensive care; Length of stay; Morbid obesity; Morbidity

Mesh:

Year:  2015        PMID: 27012877     DOI: 10.1016/j.soard.2015.11.031

Source DB:  PubMed          Journal:  Surg Obes Relat Dis        ISSN: 1550-7289            Impact factor:   4.734


  5 in total

1.  Safety of Continuous Postoperative Pulse Oximetry Monitoring Without Obstructive Sleep Apnea Screening in > 5000 Patients Undergoing Bariatric Surgery.

Authors:  Sophie L van Veldhuisen; Ibrahim Arslan; Laura N Deden; Edo O Aarts; Eric J Hazebroek
Journal:  Obes Surg       Date:  2020-03       Impact factor: 4.129

2.  A Comparative Analysis of Fleur-de-Lis and Traditional Panniculectomy after Bariatric Surgery.

Authors:  Adrienne N Christopher; Martin P Morris; Viren Patel; Harrison Davis; Robyn B Broach; John P Fischer
Journal:  Aesthetic Plast Surg       Date:  2021-02-05       Impact factor: 2.326

3.  Development of the "OS-SEV90 Score" to Predict Severe Postoperative Complications at 90 Days Following Bariatric Surgery.

Authors:  Hugo Meunier; Benjamin Menahem; Yannick Le Roux; Adrien Lee Bion; Yoann Marion; Antoine Vallois; Nicolas Contival; Thomas Gautier; Jean Lubrano; Anaïs Briant; Jean-Jacques Parienti; Arnaud Alves
Journal:  Obes Surg       Date:  2021-04-28       Impact factor: 4.129

Review 4.  The Bariatric Patient in the Intensive Care Unit: Pitfalls and Management.

Authors:  Carlos E Pompilio; Paolo Pelosi; Melina G Castro
Journal:  Curr Atheroscler Rep       Date:  2016-09       Impact factor: 5.113

Review 5.  Does Gastric Surgery (Such as Bariatric Surgery) Impact the Risk of Intestinal Inflammation?

Authors:  Daniel Gero; Christian A Gutschow; Marco Bueter
Journal:  Inflamm Intest Dis       Date:  2016-09-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.